A Comparison Study of the Detection Limit of Omicron SARS-CoV-2 Nucleocapsid by Various Rapid Antigen Tests
Abstract
:1. Introduction
2. Materials and Methods
3. Results and Discussion
4. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- The Lancet. India under COVID-19 Lockdown. Lancet 2020, 395, 1315. [Google Scholar] [CrossRef]
- Di Domenico, L.; Pullano, G.; Sabbatini, C.E.; Boëlle, P.-Y.; Colizza, V. Impact of Lockdown on COVID-19 Epidemic in Île-de-France and Possible Exit Strategies. BMC Med. 2020, 18, 240. [Google Scholar] [CrossRef] [PubMed]
- Feng, S.; Shen, C.; Xia, N.; Song, W.; Fan, M.; Cowling, B.J. Rational Use of Face Masks in the COVID-19 Pandemic. Lancet Respir. Med. 2020, 8, 434–436. [Google Scholar] [CrossRef] [PubMed]
- Chua, M.H.; Cheng, W.; Goh, S.S.; Kong, J.; Li, B.; Lim, J.Y.C.; Mao, L.; Wang, S.; Xue, K.; Yang, L.; et al. Face Masks in the New COVID-19 Normal: Materials, Testing, and Perspectives. Research 2020, 2020, 7286735. [Google Scholar] [CrossRef] [PubMed]
- Erdem, Ö.; Eş, I.; Saylan, Y.; Inci, F. Unifying the Efforts of Medicine, Chemistry, and Engineering in Biosensing Technologies to Tackle the Challenges of the COVID-19 Pandemic. Anal. Chem. 2022, 94, 3–25. [Google Scholar] [CrossRef]
- Huergo, M.A.C.; Thanh, N.T.K. Current Advances in the Detection of COVID-19 and Evaluation of the Humoral Response. Analyst 2021, 146, 382–402. [Google Scholar] [CrossRef]
- Thapa, S.; Singh, K.R.; Verma, R.; Singh, J.; Singh, R.P. State-of-the-Art Smart and Intelligent Nanobiosensors for SARS-CoV-2 Diagnosis. Biosensors 2022, 12, 637. [Google Scholar] [CrossRef]
- Asghar, R.; Rasheed, M.; ul Hassan, J.; Rafique, M.; Khan, M.; Deng, Y. Advancements in Testing Strategies for COVID-19. Biosensors 2022, 12, 410. [Google Scholar] [CrossRef]
- Wang, J.; Cai, K.; Zhang, R.; He, X.; Shen, X.; Liu, J.; Xu, J.; Qiu, F.; Lei, W.; Wang, J.; et al. Novel One-Step Single-Tube Nested Quantitative Real-Time PCR Assay for Highly Sensitive Detection of SARS-CoV-2. Anal. Chem. 2020, 92, 9399–9404. [Google Scholar] [CrossRef]
- Guglielmi, G. The Explosion of New Coronavirus Tests That Could Help to End the Pandemic. Nature 2020, 583, 506–509. [Google Scholar] [CrossRef]
- Chen, J.; Wang, R.; Gilby, N.B.; Wei, G.-W. Omicron Variant (B.1.1.529): Infectivity, Vaccine Breakthrough, and Antibody Resistance. J. Chem. Inf. Model. 2022, 62, 412–422. [Google Scholar] [CrossRef] [PubMed]
- Poudel, S.; Ishak, A.; Perez-Fernandez, J.; Garcia, E.; León-Figueroa, D.A.; Romaní, L.; Bonilla-Aldana, D.K.; Rodriguez-Morales, A.J. Highly Mutated SARS-CoV-2 Omicron Variant Sparks Significant Concern among Global Experts—What Is Known so Far? Travel Med. Infect. Dis. 2022, 45, 102234. [Google Scholar] [CrossRef] [PubMed]
- Castillo-León, J.; Trebbien, R.; Castillo, J.J.; Svendsen, W.E. Commercially Available Rapid Diagnostic Tests for the Detection of High Priority Pathogens: Status and Challenges. Analyst 2021, 146, 3750–3776. [Google Scholar] [CrossRef]
- Koczula, K.M.; Gallotta, A. Lateral Flow Assays. Essays Biochem. 2016, 60, 111–120. [Google Scholar] [CrossRef] [PubMed]
- Bai, Z.; Cao, Y.; Liu, W.; Li, J. The SARS-CoV-2 Nucleocapsid Protein and Its Role in Viral Structure, Biological Functions, and a Potential Target for Drug or Vaccine Mitigation. Viruses 2021, 13, 1115. [Google Scholar] [CrossRef]
- Che, X.-Y.; Hao, W.; Wang, Y.; Di, B.; Yin, K.; Xu, Y.-C.; Feng, C.-S.; Wan, Z.-Y.; Cheng, V.C.C.; Yuen, K.-Y. Nucleocapsid Protein as Early Diagnostic Marker for SARS. Emerg. Infect. Dis. 2004, 10, 1947–1949. [Google Scholar] [CrossRef] [PubMed]
- Lu, S.; Ye, Q.; Singh, D.; Cao, Y.; Diedrich, J.K.; Yates, J.R.; Villa, E.; Cleveland, D.W.; Corbett, K.D. The SARS-CoV-2 Nucleocapsid Phosphoprotein Forms Mutually Exclusive Condensates with RNA and the Membrane-Associated M Protein. Nat. Commun. 2021, 12, 502. [Google Scholar] [CrossRef] [PubMed]
- Diao, B.; Wen, K.; Zhang, J.; Chen, J.; Han, C.; Chen, Y.; Wang, S.; Deng, G.; Zhou, H.; Wu, Y. Accuracy of a Nucleocapsid Protein Antigen Rapid Test in the Diagnosis of SARS-CoV-2 Infection. Clin. Microbiol. Infect. 2021, 27, 289.e1–289.e4. [Google Scholar] [CrossRef] [PubMed]
- Mak, G.C.; Cheng, P.K.; Lau, S.S.; Wong, K.K.; Lau, C.; Lam, E.T.; Chan, R.C.; Tsang, D.N. Evaluation of Rapid Antigen Test for Detection of SARS-CoV-2 Virus. J. Clin. Virol. 2020, 129, 104500. [Google Scholar] [CrossRef]
- Porte, L.; Legarraga, P.; Vollrath, V.; Aguilera, X.; Munita, J.M.; Araos, R.; Pizarro, G.; Vial, P.; Iruretagoyena, M.; Dittrich, S.; et al. Evaluation of a Novel Antigen-Based Rapid Detection Test for the Diagnosis of SARS-CoV-2 in Respiratory Samples. Int. J. Infect. Dis. 2020, 99, 328–333. [Google Scholar] [CrossRef]
- Osterman, A.; Badell, I.; Basara, E.; Stern, M.; Kriesel, F.; Eletreby, M.; Öztan, G.N.; Huber, M.; Autenrieth, H.; Knabe, R.; et al. Impaired Detection of Omicron by SARS-CoV-2 Rapid Antigen Tests. Med. Microbiol. Immunol. 2022, 2022, 730. [Google Scholar] [CrossRef] [PubMed]
- Cubas-Atienzar, A.I.; Kontogianni, K.; Edwards, T.; Wooding, D.; Buist, K.; Thompson, C.R.; Williams, C.T.; Patterson, E.I.; Hughes, G.L.; Baldwin, L.; et al. Limit of Detection in Different Matrices of 19 Commercially Available Rapid Antigen Tests for the Detection of SARS-CoV-2. Sci. Rep. 2021, 11, 18313. [Google Scholar] [CrossRef] [PubMed]
- Stanley, S.; Hamel, D.J.; Wolf, I.D.; Riedel, S.; Dutta, S.; Contreras, E.; Callahan, C.J.; Cheng, A.; Arnaout, R.; Kirby, J.E.; et al. Limit of Detection for Rapid Antigen Testing of the SARS-CoV-2 Omicron and Delta Variants of Concern Using Live-Virus Culture. J. Clin. Microbiol. 2022, 60, 22. [Google Scholar] [CrossRef]
- Dinnes, J.; Sharma, P.; Berhane, S.; van Wyk, S.S.; Nyaaba, N.; Domen, J.; Taylor, M.; Cunningham, J.; Davenport, C.; Dittrich, S.; et al. Rapid, Point-of-Care Antigen Tests for Diagnosis of SARS-CoV-2 Infection. Cochrane Database Syst. Rev. 2022, 2022, CD013705. [Google Scholar] [CrossRef]
- Chu, V.T.; Schwartz, N.G.; Donnelly, M.A.P.; Chuey, M.R.; Soto, R.; Yousaf, A.R.; Schmitt-Matzen, E.N.; Sleweon, S.; Ruffin, J.; Thornburg, N.; et al. Comparison of Home Antigen Testing with RT-PCR and Viral Culture during the Course of SARS-CoV-2 Infection. JAMA Intern. Med. 2022, 182, 701–709. [Google Scholar] [CrossRef]
- Choi, J.R.; Hu, J.; Feng, S.; Wan Abas, W.A.B.; Pingguan-Murphy, B.; Xu, F. Sensitive Biomolecule Detection in Lateral Flow Assay with a Portable Temperature–Humidity Control Device. Biosens. Bioelectron. 2016, 79, 98–107. [Google Scholar] [CrossRef]
- Klein, S.; Cortese, M.; Winter, S.L.; Wachsmuth-Melm, M.; Neufeldt, C.J.; Cerikan, B.; Stanifer, M.L.; Boulant, S.; Bartenschlager, R.; Chlanda, P. SARS-CoV-2 Structure and Replication Characterized by in Situ Cryo-Electron Tomography. Nat. Commun. 2020, 11, 5885. [Google Scholar] [CrossRef] [PubMed]
- Singanayagam, A.; Hakki, S.; Dunning, J.; Madon, K.J.; Crone, M.A.; Koycheva, A.; Derqui-Fernandez, N.; Barnett, J.L.; Whitfield, M.G.; Varro, R.; et al. Community Transmission and Viral Load Kinetics of the SARS-CoV-2 Delta (B.1.617.2) Variant in Vaccinated and Unvaccinated Individuals in the UK: A Prospective, Longitudinal, Cohort Study. Lancet Infect. Dis. 2022, 22, 183–195. [Google Scholar] [CrossRef]
- Puhach, O.; Adea, K.; Hulo, N.; Sattonnet, P.; Genecand, C.; Iten, A.; Bausch, F.J.; Kaiser, L.; Vetter, P.; Eckerle, I.; et al. Infectious Viral Load in Unvaccinated and Vaccinated Individuals Infected with Ancestral, Delta or Omicron SARS-CoV-2. Nat. Med. 2022, 2022, 816. [Google Scholar] [CrossRef]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Dobrynin, D.; Polischuk, I.; Pokroy, B. A Comparison Study of the Detection Limit of Omicron SARS-CoV-2 Nucleocapsid by Various Rapid Antigen Tests. Biosensors 2022, 12, 1083. https://doi.org/10.3390/bios12121083
Dobrynin D, Polischuk I, Pokroy B. A Comparison Study of the Detection Limit of Omicron SARS-CoV-2 Nucleocapsid by Various Rapid Antigen Tests. Biosensors. 2022; 12(12):1083. https://doi.org/10.3390/bios12121083
Chicago/Turabian StyleDobrynin, Daniela, Iryna Polischuk, and Boaz Pokroy. 2022. "A Comparison Study of the Detection Limit of Omicron SARS-CoV-2 Nucleocapsid by Various Rapid Antigen Tests" Biosensors 12, no. 12: 1083. https://doi.org/10.3390/bios12121083
APA StyleDobrynin, D., Polischuk, I., & Pokroy, B. (2022). A Comparison Study of the Detection Limit of Omicron SARS-CoV-2 Nucleocapsid by Various Rapid Antigen Tests. Biosensors, 12(12), 1083. https://doi.org/10.3390/bios12121083